Projects per year
Abstract
Many risk factors for dementia, identified from observational studies, are potentially modifiable. This raises the possibility that targeting key modifiable dementia risk factors may reduce the prevalence of dementia, which has led to the development of dementia risk reduction and prevention strategies, such as intervention trials or dementia prevention guidelines. However, what has rarely been considered in the studies that inform these strategies is the extent to which modifiable dementia risk factors can (1) be identified by individuals, and (2) be readily modified by individuals. Characteristics of modifiable dementia risk factors such as readiness of identification and targeting, as well as when they should be targeted, can influence the design, or success of strategies for reducing dementia risk. This review aims to develop a framework for classifying the degree of modifiability of dementia risk factors for research studies. The extent to which these modifiable dementia risk factors could be modified by an individual seeking to reduce their dementia risk is determined, as well as the resources that might be needed for both risk factor identification and modification, and whether modification may be optimal in early-life (aged <45 years), midlife (aged 45–65 years) or late-life (aged >65 years). Finally, barriers that could influence the ability of an individual to engage in risk factor modification and, ultimately, dementia risk reduction are discussed.
Original language | English |
---|---|
Pages (from-to) | 22-37 |
Number of pages | 16 |
Journal | The Journal of Prevention of Alzheimer's Disease |
Volume | 11 |
DOIs | |
Publication status | Published - 2024 |
Keywords
- Alzheimer’s disease
- Dementia
- modifiable
- prevention
- risk factors
- risk reduction
-
Risk and resilience in Alzheimer's pathogenesis, cognitive decline and clinical disease progression
Lim, Y. Y. (Primary Chief Investigator (PCI))
1/01/22 → 31/12/26
Project: Research
-
BetterBrains: Person-Centred, Multi-domain, primary prevention strategies to delay memory decline
Lim, Y. Y. (Primary Chief Investigator (PCI)), Barker, A. (Chief Investigator (CI)), Pase, M. (Chief Investigator (CI)), Maruff, P. T. (Chief Investigator (CI)), Yassi, N. (Chief Investigator (CI)), Ayton, D. (Chief Investigator (CI)), Churilov, L. (Chief Investigator (CI)), Sinnott, R. O. (Chief Investigator (CI)), Buckley, R. (Chief Investigator (CI)) & Barton, C. (Chief Investigator (CI))
4/05/20 → 31/07/25
Project: Research
-
Biological, genetic and lifestyle moderators of Alzheimer's pathogenesis, cognitive decline and clinical disease progression
Lim, Y. Y. (Primary Chief Investigator (PCI))
National Health and Medical Research Council (NHMRC) (Australia)
4/05/20 → 31/12/22
Project: Research